 | • レポートコード：MRC2012A2032 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、コレラワクチン経口ライブの世界市場を広く調査・分析し、今後の市場展望をまとめております。コレラワクチン経口ライブの種類別市場規模（ﾄﾞｩｺﾗﾙ、シャンコール、ヴァクスコラ、その他）、用途別市場規模（病院、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Valneva、Celldex Therapeutics、PaxVax、Shantha Biotechnics Limited、Ceva Asia、Merck、 ・地域別グローバル市場分析 2015年-2020年 ・コレラワクチン経口ライブの北米市場（アメリカ、カナダ、メキシコ） ・コレラワクチン経口ライブのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・コレラワクチン経口ライブのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・コレラワクチン経口ライブの南米市場（ブラジル、アルゼンチン） ・コレラワクチン経口ライブの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ﾄﾞｩｺﾗﾙ、シャンコール、ヴァクスコラ、その他 ・用途別分析：病院、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cholera Vaccines Oral Live market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cholera Vaccines Oral Live market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cholera Vaccines Oral Live market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cholera Vaccines Oral Live market has been segmented into
Dukoral
Shanchol
Vaxchora
Others
By Application, Cholera Vaccines Oral Live has been segmented into:
Hospital
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cholera Vaccines Oral Live market presented in the report. This section sheds light on the sales growth of different regional and country-level Cholera Vaccines Oral Live markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cholera Vaccines Oral Live market.
The report offers in-depth assessment of the growth and other aspects of the Cholera Vaccines Oral Live market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cholera Vaccines Oral Live Market Share Analysis
Cholera Vaccines Oral Live competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cholera Vaccines Oral Live sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cholera Vaccines Oral Live sales, revenue and market share for each player covered in this report.
The major players covered in Cholera Vaccines Oral Live are:
Valneva
Celldex Therapeutics
PaxVax
Shantha Biotechnics Limited
Ceva Asia
Merck
Among other players domestic and global, Cholera Vaccines Oral Live market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cholera Vaccines Oral Live product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cholera Vaccines Oral Live, with price, sales, revenue and global market share of Cholera Vaccines Oral Live in 2018 and 2019.
Chapter 3, the Cholera Vaccines Oral Live competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccines Oral Live breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cholera Vaccines Oral Live market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cholera Vaccines Oral Live sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cholera Vaccines Oral Live Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cholera Vaccines Oral Live Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Dukoral
1.2.3 Shanchol
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cholera Vaccines Oral Live Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Cholera Vaccines Oral Live Market
1.4.1 Global Cholera Vaccines Oral Live Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Valneva
2.1.1 Valneva Details
2.1.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Valneva SWOT Analysis
2.1.4 Valneva Product and Services
2.1.5 Valneva Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celldex Therapeutics
2.2.1 Celldex Therapeutics Details
2.2.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celldex Therapeutics SWOT Analysis
2.2.4 Celldex Therapeutics Product and Services
2.2.5 Celldex Therapeutics Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 PaxVax
2.3.1 PaxVax Details
2.3.2 PaxVax Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 PaxVax SWOT Analysis
2.3.4 PaxVax Product and Services
2.3.5 PaxVax Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Shantha Biotechnics Limited
2.4.1 Shantha Biotechnics Limited Details
2.4.2 Shantha Biotechnics Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Shantha Biotechnics Limited SWOT Analysis
2.4.4 Shantha Biotechnics Limited Product and Services
2.4.5 Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ceva Asia
2.5.1 Ceva Asia Details
2.5.2 Ceva Asia Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ceva Asia SWOT Analysis
2.5.4 Ceva Asia Product and Services
2.5.5 Ceva Asia Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cholera Vaccines Oral Live Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cholera Vaccines Oral Live Manufacturer Market Share in 2019
3.3.2 Top 6 Cholera Vaccines Oral Live Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cholera Vaccines Oral Live Sales, Revenue and Market Share by Regions
4.1.1 Global Cholera Vaccines Oral Live Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Regions (2015-2020)
4.2 North America Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
4.3 Europe Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
4.5 South America Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cholera Vaccines Oral Live Sales, Revenue and Market Share by Country
5.1.1 North America Cholera Vaccines Oral Live Sales and Market Share by Country (2015-2020)
5.1.2 North America Cholera Vaccines Oral Live Revenue and Market Share by Country (2015-2020)
5.2 United States Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
5.3 Canada Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
5.4 Mexico Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cholera Vaccines Oral Live Sales, Revenue and Market Share by Country
6.1.1 Europe Cholera Vaccines Oral Live Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cholera Vaccines Oral Live Revenue and Market Share by Country (2015-2020)
6.2 Germany Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
6.3 UK Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
6.4 France Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
6.5 Russia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
6.6 Italy Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cholera Vaccines Oral Live Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cholera Vaccines Oral Live Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cholera Vaccines Oral Live Revenue and Market Share by Regions (2015-2020)
7.2 China Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
7.3 Japan Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
7.4 Korea Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
7.5 India Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
7.7 Australia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cholera Vaccines Oral Live Sales, Revenue and Market Share by Country
8.1.1 South America Cholera Vaccines Oral Live Sales and Market Share by Country (2015-2020)
8.1.2 South America Cholera Vaccines Oral Live Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
8.3 Argentina Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cholera Vaccines Oral Live Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cholera Vaccines Oral Live Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cholera Vaccines Oral Live Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
9.3 Turkey Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
9.4 Egypt Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
9.5 South Africa Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cholera Vaccines Oral Live Sales and Market Share by Type (2015-2020)
10.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Type (2015-2020)
10.3 Global Cholera Vaccines Oral Live Price by Type (2015-2020)
11 Global Cholera Vaccines Oral Live Market Segment by Application
11.1 Global Cholera Vaccines Oral Live Sales Market Share by Application (2015-2020)
11.2 Global Cholera Vaccines Oral Live Revenue Market Share by Application (2015-2020)
11.3 Global Cholera Vaccines Oral Live Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cholera Vaccines Oral Live Sales, Revenue and Growth Rate (2021-2025)
12.2 Cholera Vaccines Oral Live Market Forecast by Regions (2021-2025)
12.2.1 North America Cholera Vaccines Oral Live Market Forecast (2021-2025)
12.2.2 Europe Cholera Vaccines Oral Live Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cholera Vaccines Oral Live Market Forecast (2021-2025)
12.2.4 South America Cholera Vaccines Oral Live Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cholera Vaccines Oral Live Market Forecast (2021-2025)
12.3 Cholera Vaccines Oral Live Market Forecast by Type (2021-2025)
12.3.1 Global Cholera Vaccines Oral Live Sales Forecast by Type (2021-2025)
12.3.2 Global Cholera Vaccines Oral Live Market Share Forecast by Type (2021-2025)
12.4 Cholera Vaccines Oral Live Market Forecast by Application (2021-2025)
12.4.1 Global Cholera Vaccines Oral Live Sales Forecast by Application (2021-2025)
12.4.2 Global Cholera Vaccines Oral Live Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cholera Vaccines Oral Live Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cholera Vaccines Oral Live by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cholera Vaccines Oral Live Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Valneva Basic Information, Manufacturing Base and Competitors
Table 8. Valneva Cholera Vaccines Oral Live Major Business
Table 9. Valneva Cholera Vaccines Oral Live Total Revenue (USD Million) (2017-2018)
Table 10. Valneva SWOT Analysis
Table 11. Valneva Cholera Vaccines Oral Live Product and Services
Table 12. Valneva Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Celldex Therapeutics Cholera Vaccines Oral Live Major Business
Table 15. Celldex Therapeutics Cholera Vaccines Oral Live Total Revenue (USD Million) (2017-2018)
Table 16. Celldex Therapeutics SWOT Analysis
Table 17. Celldex Therapeutics Cholera Vaccines Oral Live Product and Services
Table 18. Celldex Therapeutics Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. PaxVax Basic Information, Manufacturing Base and Competitors
Table 20. PaxVax Cholera Vaccines Oral Live Major Business
Table 21. PaxVax Cholera Vaccines Oral Live Total Revenue (USD Million) (2017-2018)
Table 22. PaxVax SWOT Analysis
Table 23. PaxVax Cholera Vaccines Oral Live Product and Services
Table 24. PaxVax Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Shantha Biotechnics Limited Basic Information, Manufacturing Base and Competitors
Table 26. Shantha Biotechnics Limited Cholera Vaccines Oral Live Major Business
Table 27. Shantha Biotechnics Limited Cholera Vaccines Oral Live Total Revenue (USD Million) (2017-2018)
Table 28. Shantha Biotechnics Limited SWOT Analysis
Table 29. Shantha Biotechnics Limited Cholera Vaccines Oral Live Product and Services
Table 30. Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ceva Asia Basic Information, Manufacturing Base and Competitors
Table 32. Ceva Asia Cholera Vaccines Oral Live Major Business
Table 33. Ceva Asia Cholera Vaccines Oral Live Total Revenue (USD Million) (2017-2018)
Table 34. Ceva Asia SWOT Analysis
Table 35. Ceva Asia Cholera Vaccines Oral Live Product and Services
Table 36. Ceva Asia Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Cholera Vaccines Oral Live Major Business
Table 39. Merck Cholera Vaccines Oral Live Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Cholera Vaccines Oral Live Product and Services
Table 42. Merck Cholera Vaccines Oral Live Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Cholera Vaccines Oral Live Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global Cholera Vaccines Oral Live Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Cholera Vaccines Oral Live Sales by Regions (2015-2020) (K Units)
Table 46. Global Cholera Vaccines Oral Live Sales Market Share by Regions (2015-2020)
Table 47. Global Cholera Vaccines Oral Live Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Cholera Vaccines Oral Live Sales by Countries (2015-2020) (K Units)
Table 49. North America Cholera Vaccines Oral Live Sales Market Share by Countries (2015-2020)
Table 50. North America Cholera Vaccines Oral Live Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Cholera Vaccines Oral Live Revenue Market Share by Countries (2015-2020)
Table 52. Europe Cholera Vaccines Oral Live Sales by Countries (2015-2020) (K Units)
Table 53. Europe Cholera Vaccines Oral Live Sales Market Share by Countries (2015-2020)
Table 54. Europe Cholera Vaccines Oral Live Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Cholera Vaccines Oral Live Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific Cholera Vaccines Oral Live Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Cholera Vaccines Oral Live Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Cholera Vaccines Oral Live Sales by Countries (2015-2020) (K Units)
Table 59. South America Cholera Vaccines Oral Live Sales Market Share by Countries (2015-2020)
Table 60. South America Cholera Vaccines Oral Live Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Cholera Vaccines Oral Live Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Cholera Vaccines Oral Live Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Cholera Vaccines Oral Live Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Cholera Vaccines Oral Live Revenue Market Share by Countries (2015-2020)
Table 66. Global Cholera Vaccines Oral Live Sales by Type (2015-2020) (K Units)
Table 67. Global Cholera Vaccines Oral Live Sales Share by Type (2015-2020)
Table 68. Global Cholera Vaccines Oral Live Revenue by Type (2015-2020) (USD Million)
Table 69. Global Cholera Vaccines Oral Live Revenue Share by Type (2015-2020)
Table 70. Global Cholera Vaccines Oral Live Sales by Application (2015-2020) (K Units)
Table 71. Global Cholera Vaccines Oral Live Sales Share by Application (2015-2020)
Table 72. Global Cholera Vaccines Oral Live Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global Cholera Vaccines Oral Live Market Share Forecast by Regions (2021-2025)
Table 74. Global Cholera Vaccines Oral Live Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global Cholera Vaccines Oral Live Market Share Forecast by Type (2021-2025)
Table 76. Global Cholera Vaccines Oral Live Sales Forecast by Application (2021-2025)
Table 77. Global Cholera Vaccines Oral Live Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cholera Vaccines Oral Live Picture
Figure 2. Global Sales Market Share of Cholera Vaccines Oral Live by Type in 2019
Figure 3. Dukoral Picture
Figure 4. Shanchol Picture
Figure 5. Vaxchora Picture
Figure 6. Others Picture
Figure 7. Cholera Vaccines Oral Live Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Scientific Research Picture
Figure 10. Others Picture
Figure 11. Global Cholera Vaccines Oral Live Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Cholera Vaccines Oral Live Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Cholera Vaccines Oral Live Sales Market Share by Manufacturer in 2019
Figure 32. Global Cholera Vaccines Oral Live Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Cholera Vaccines Oral Live Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Cholera Vaccines Oral Live Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Cholera Vaccines Oral Live Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Cholera Vaccines Oral Live Revenue Market Share by Regions (2015-2020)
Figure 39. Global Cholera Vaccines Oral Live Revenue Market Share by Regions in 2018
Figure 40. North America Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
Figure 41. Europe Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
Figure 43. South America Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020)
Figure 45. North America Cholera Vaccines Oral Live Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Cholera Vaccines Oral Live Sales Market Share by Countries (2015-2020)
Figure 47. North America Cholera Vaccines Oral Live Sales Market Share by Countries in 2018
Figure 48. North America Cholera Vaccines Oral Live Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Cholera Vaccines Oral Live Revenue Market Share by Countries in 2018
Figure 50. United States Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Cholera Vaccines Oral Live Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Cholera Vaccines Oral Live Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Cholera Vaccines Oral Live Revenue Market Share by Countries in 2019
Figure 56. Germany Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Cholera Vaccines Oral Live Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Cholera Vaccines Oral Live Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Cholera Vaccines Oral Live Revenue Market Share by Regions 2019
Figure 64. China Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Cholera Vaccines Oral Live Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Cholera Vaccines Oral Live Sales Market Share by Countries in 2019
Figure 71. South America Cholera Vaccines Oral Live Revenue Market Share by Countries in 2019
Figure 72. Brazil Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Cholera Vaccines Oral Live Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Cholera Vaccines Oral Live Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Cholera Vaccines Oral Live Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Cholera Vaccines Oral Live Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Cholera Vaccines Oral Live Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Cholera Vaccines Oral Live Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Cholera Vaccines Oral Live Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Cholera Vaccines Oral Live Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Cholera Vaccines Oral Live Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Cholera Vaccines Oral Live Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Cholera Vaccines Oral Live Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Cholera Vaccines Oral Live Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
フルミストワクチンの世界市場（～2026年） An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated…- 全細胞コレラワクチンの世界市場（～2026年） Whole Cell Cholera Vaccine is used to prevent Cholera. The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries. Market Ana…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- H7N9ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global H7N9 Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The H7N9 Vaccines market report pro…